Skip to main content
SpringerLink
Log in

Pathology of Neuroendocrine Lesions of GI Tract

  • Chapter
  • First Online:
Surgical Pathology of the Gastrointestinal System

  • 1739 Accesses

Abstract

Neuroendocrine neoplasms of the gastrointestinal tract (GIT) present a challenge to clinicians as well as to pathologists. Their nomenclature, classification, and diagnostic criteria are revamped frequently, as new knowledge emerges. This chapter covers the current knowledge on this topic, including the classification of neuroendocrine neoplasms of the luminal GIT, and describes in detail the pathophysiology, histomorphological, immunohistochemical, and molecular features of these tumors at each specific location in the GIT.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kim JY, Hong SM. Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts. Arch Pathol Lab Med. 2016;140(5):437–48.

    Article  CAS  Google Scholar 

  2. Grin A, Streutker CJ. Neuroendocrine tumors of the luminal gastrointestinal tract. Arch Pathol Lab Med. 2015;139:750–6.

    Article  CAS  Google Scholar 

  3. Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI. Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms. Ann Transl Med. 2018;6:252.

    Article  Google Scholar 

  4. Wang HL, Kim CJ, Koo J, Zhou W, Choi EK, Arcega R, Chen ZE, Wang H, Zhang L, Lin F. Practical immunohistochemistry in neoplastic pathology of the gastrointestinal tract, liver, biliary tract, and pancreas. Arch Pathol Lab Med. 2017;141(9):1155–80.

    Article  CAS  Google Scholar 

  5. González I, Lu HC, Sninsky J, Yang C, Bishnupuri K, Dieckgraefe B, Cao D, Chatterjee D. Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts. Histopathology. 2019;75:568–77.

    Article  Google Scholar 

  6. Patel N, Barbieri A, Gibson J. Neuroendocrine tumors of the gastrointestinal tract and pancreas. Surg Pathol Clin. 2019;12(4):1021–44.

    Article  Google Scholar 

  7. Klimstra DS, Kloppel G, La Rosa S, Rindi G. Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours Editorial Board, editors. Digestive system tumors. 5th ed. Lyon: IARC; 2019. p. 16–9.

    Google Scholar 

  8. McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol. 2013;37:1671–7.

    Article  Google Scholar 

  9. Reid MD, Bagci P, Ohike N, Saka B, Erbarut Seven I, Dursun N, Balci S, Gucer H, Jang KT, Tajiri T, Basturk O, Kong SY, Goodman M, Akkas G, Adsay V. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Mod Pathol. 2015;28:686–94.

    Article  Google Scholar 

  10. Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U. Predictive and prognostic fac- tors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol. 2013;24:152–60.

    Article  CAS  Google Scholar 

  11. Huang Q, Wu H, Nie L, Shi J, Lebenthal A, Chen J, Sun Q, Yang J, Huang L, Ye Q. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol. 2013;37:467–83.

    Article  Google Scholar 

  12. Rinke A, Gress TM. Neuroendocrine cancer, therapeutic strategies in G3 cancers. Digestion. 2017;95(2):109–14.

    Article  CAS  Google Scholar 

  13. Hadoux J, Blanchard P, Scoazec JY, Burtin P, Planchard D, Malka D, Berdelou A, Boige V, Duvillard P, Leboulleux S, Faron M, Tselikas L, Deutsch E, Ducreux M, Baudin E. Post-radiation grade 3 neuroendocrine carcinoma: a new entity? Neuroendocrinology. 2021;111(1–2):139–45.

    Article  CAS  Google Scholar 

  14. La Rosa S, Sessa F, Uccella S. Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms. Endocr Pathol. 2016;27:284–311.

    Article  Google Scholar 

  15. Uccella S, La Rosa S. Looking into digestive mixed neuroendocrine-nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors. Histopathology. 2020;77(5):700–17.

    Article  Google Scholar 

  16. Frizziero M, Chakrabarty B, Nagy B, Lamarca A, Hubner RA, Valle JW, McNamara MG. Mixed neuroendocrine non-neuroendocrine neoplasms: a systematic review of a controversial and underestimated diagnosis. J Clin Med. 2020;9(1):273.

    Article  Google Scholar 

  17. Hoang MP, Hobbs CM, Sobin LH, Albores-Saavedra J. Carcinoid tumor of the esophagus: a clinicopathologic study of four cases. Am J Surg Pathol. 2002;26(4):517–22.

    Article  Google Scholar 

  18. Lim JS, Kurtz J, Borscheid R, Cho E, Osman H, Jeyarajah DR. Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the esophagus. Am Surg. 2020;86(2):e101–3.

    Article  Google Scholar 

  19. Stawarski A, Maleika P. Neuroendocrine tumors of the gastrointestinal tract and pancreas: is it also a challenge for pediatricians? Adv Clin Exp Med. 2020;29(2):265–70.

    Article  Google Scholar 

  20. Puccini A, Poorman K, Salem ME, Soldato D, Seeber A, Goldberg RM, Shields AF, Xiu J, Battaglin F, Berger MD, Tokunaga R, Naseem M, Barzi A, Iqbal S, Zhang W, Soni S, Hwang JJ, Philip PA, Sciallero S, Korn WM, Marshall JL, Lenz HJ. Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). Clin Cancer Res. 2020;26(22):5943–51.

    Article  CAS  Google Scholar 

  21. Jesinghaus M, Konukiewitz B, Keller G, et al. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas. Mod Pathol. 2017;30:610–9.

    Article  CAS  Google Scholar 

  22. Ye L, Lu H, Wu L, Zhang L, Shi H, Wu HM, Tu P, Li M, Wang FY. The clinicopathologic features and prognosis of esophageal neuroendocrine carcinomas: a single-center study of 53 resection cases. BMC Cancer. 2019;19(1):1234.

    Article  CAS  Google Scholar 

  23. Choe AR, Shim KN, Lim J, Song EM, Tae CH, Jung SA, Jo MS. A collision tumor of the esophagus: mixed squamous cell carcinoma and neuroendocrine carcinoma. Korean J Gastroenterol. 2020;75(4):207–11.

    Article  Google Scholar 

  24. O’Toole D, Delle Fave G, Jensen RT. Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012;26(6):719–35.

    Article  Google Scholar 

  25. Li TT, Qiu F, Qian ZR, Wan J, Qi XK, Wu BY. Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors. World J Gastroenterol. 2014;20(1):118–25.

    Article  Google Scholar 

  26. Latta E, Rotondo F, Leiter LA, Horvath E, Kovacs K. Ghrelin- and serotonin-producing gastric carcinoid. J Gastrointest Cancer. 2012;43(2):319–23.

    Article  Google Scholar 

  27. La Rosa S, Rindi G, Solcia E, Tang LH. Gastric neuroendocrine neoplasms. In: WHO Classification of Tumours Editorial Board, editors. Digestive system tumors. 5th ed. Lyon: IARC; 2019. p. 104–9.

    Google Scholar 

  28. Tartaglia A, Vezzadini C, Bianchini S, Vezzadini P. Gastrinoma of the stomach: a case report. Int J Gastrointest Cancer. 2005;35(3):211–6.

    Article  Google Scholar 

  29. Yamashita S, Abe H, Kunita A, Yamashita H, Seto Y, Ushiku T. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma. Histopathology. 2020; https://doi.org/10.1111/his.14230.

  30. Keck KJ, Maxwell JE, Utria AF, Bellizzi AM, Dillon JS, O’Dorisio TM, Howe JR. The distal predilection of small bowel neuroendocrine tumors. Ann Surg Oncol. 2018;25:3207–13.

    Article  Google Scholar 

  31. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19:991–1002.

    Article  CAS  Google Scholar 

  32. Park HK, Han HS. Duodenal gangliocytic paraganglioma with lymph node metastasis. Arch Pathol Lab Med. 2016;140:94–8.

    Article  CAS  Google Scholar 

  33. Hrabe J. Neuroendocrine tumors of the appendix, colon, and rectum. Surg Oncol Clin N Am. 2020;29:267–79.

    Article  Google Scholar 

  34. Misdraji J, Carr NJ, Pai RK. Appendiceal goblet cell adenocarcinoma. In: WHO Classification of Tumours Editorial Board, editors. Digestive system tumors. 5th ed. Lyon: IARC; 2019. p 149–51.

    Google Scholar 

  35. Zhang K, Meyerson C, Kassardjian A, Westbrook LM, Zheng W, Wang HL. Goblet cell carcinoid/carcinoma: an update. Adv Anat Pathol. 2019;26(2):75–83.

    Article  CAS  Google Scholar 

  36. Pape UF, Niederle B, Costa F, Gross D, Kelestimur F, Kianmanesh R, Knigge U, Öberg K, Pavel M, Perren A, Toumpanakis C, O’Connor J, Krenning E, Reed N, O’Toole D, Vienna Consensus Conference Participants. ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas). Neuroendocrinology. 2016;103:144–52.

    Article  CAS  Google Scholar 

  37. Lee SH, Kim BC, Chang HJ, et al. Rectal neuroendocrine and L-cell tumors: diagnostic dilemma and therapeutic strategy. Am J Surg Pathol. 2013;37:1044–52.

    Article  Google Scholar 

  38. Takizawa N, Ohishi Y, Hirahashi M, Takahashi S, Nakamura K, Tanaka M, Oki E, Takayanagi R, Oda Y. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor. Hum Pathol. 2015;46:1890–900.

    Article  CAS  Google Scholar 

  39. Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Amin T, Viol F, Fehrle W, Dum D, Höflmayer D, Burandt E, Clauditz TS, Perez D, Izbicki J, Wilczak W, Sauter G, Steurer S, Schrader J. Homogeneous MMR deficiency throughout the entire tumor mass occurs in a subset of colorectal neuroendocrine carcinomas. Endocr Pathol. 2020; https://doi.org/10.1007/s12022-020-09612-7. [Epub ahead of print].

Download references

Disclaimer

The authors agree to the fact that all biopsy procedures and surgical resections were performed after taking informed consent from respective patients as per the individual Institutional policies, which also includes consent for publishing the unidentified clinical images for publication or research purposes. The authors also declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Aanchal Kakkar, Rajni Yadav & Mehar C. Sharma

Authors
  1. Aanchal Kakkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rajni Yadav
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehar C. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

  2. Department of Pathology, Al Sabah Hospital, Kuwait City, Kuwait

    Kaushik Majumdar

  3. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Siddhartha Datta Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kakkar, A., Yadav, R., Sharma, M.C. (2022). Pathology of Neuroendocrine Lesions of GI Tract. In: Das, P., Majumdar, K., Datta Gupta, S. (eds) Surgical Pathology of the Gastrointestinal System. Springer, Singapore. https://doi.org/10.1007/978-981-16-6395-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-6395-6_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-6394-9

  • Online ISBN: 978-981-16-6395-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation